Key result
J-Valve TAVI yields similar 1-year survival to Venus-A and SAPIEN but is linked to fewer pacemakers.
Why the study?
It was unknown whether the frame design of transcatheter heart valves affects procedural and clinical outcomes of TAVI.
Does the frame design of transcatheter heart valves affect procedural and 1-year clinical results in patients with aortic stenosis undergoing TAVI?
Cohort (n=163)
Yes
Does the frame design of transcatheter heart valves affect procedural and 1-year clinical results in patients with aortic stenosis undergoing TAVI?
Different transcatheter heart valve frame designs affect valve hemodynamics and pacemaker implantation rates but do not significantly impact 1-year survival in patients undergoing TAVI.
Answers are grounded in this paper and cite their sources.
Similar survival supports TAVI valve flexibility; observational data leaves open causal effects of frame design on pacemaker rates.
Our study aimed to investigate whether the frame design of transcatheter heart valve (THV) affects the procedural and clinical results of transcatheter aortic valve implantation (TAVI).We retrospectively reviewed 163 patients with aortic stenosis who underwent TAVI using different types of THV (Edwards SAPIEN, n = 31; Venus-A, n = 63; and J-Valve, n = 69). The procedural outcomes and follow-up results for 1-year were compared among groups.The patients who underwent TAVI using J-Valve had a higher mean transaortic pressure gradient than those using SAPIEN or Venus-A after TAVI (1-year follow-up; P = 0.017, P < 0.001, respectively), whereas no difference was observed between the patients with SAPIEN and Venus-A prosthesis (P = 0.150). The incidence of permanent pacemaker implantation was highest in patients with Venus-A (19.0%), followed by SAPIEN (9.7%), and lowest in J-Valve (4.3%) (P = 0.025). No difference was observed in the 30-day mortality rate among the groups (P = 1.000). Moreover, Kaplan-Meier survival analysis revealed that there was no significant difference in the 1-year cumulative patient survival rate among three patient cohorts (log-rank, P = 0.850).The frame design of THVs could affect the valve-related hemodynamics and the incidence of permanent pacemaker implantation in TAVI, whereas it did not influence the survival rate of TAVI patients during 1-year follow-up period. All three THVs provided a convincing short-term outcome for TAVI patients.
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) conducted a cohort in Aortic stenosis (n=163). Transcatheter aortic valve implantation (TAVI) using J-Valve vs. TAVI using Venus-A or Edwards SAPIEN was evaluated on 1-year cumulative survival rate (p=0.850). TAVI using J-Valve, Venus-A, or Edwards SAPIEN prostheses yielded similar 1-year survival rates (90.8%, 93.7%, 93.5%; P=0.850), while J-Valve had the lowest permanent pacemaker implantation rate.
Synapse has enriched 10 related papers. Consider them for comparative context: